Late-onset Morbus Hailey-Hailey.

Autor: Debeuf MPH; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands., Verkouteren BJA; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands., Gostyński AH; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands., Hamid MA; Department of Pathology, Maastricht University Medical Center+, Maastricht, The Netherlands., Van Geel M; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands, Department of Clinical Genetics, Maastricht University Medical Center+, Maastricht, The Netherlands., Steijlen PM; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands., Verstraeten VLRM; Department of Dermatology, Maastricht University Medical Center+, Center of Expertise for Genodermatoses, Maastricht, The Netherlands, GROW Research Institute for Oncology and reproduction Maastricht University, Maastricht, The Netherlands, Dermadok Huidkliniek, Antwerp, Belgium.

Publikováno v: European journal of dermatology : EJD [Eur J Dermatol] 2024 Apr 01; Vol. 34 (2), pp. 218-219.

Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study.

Autor: Verkouteren BJA; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Oostewechel LCF; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands., Sinx KAE; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Arits AHMM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Dermatology, Catherina Hospital, Eindhoven, The Netherlands., Vernemmen AIP; Department of Pathology, Maastricht University, Maastricht, The Netherlands., Winnepenninckx VJL; Department of Pathology, Maastricht University, Maastricht, The Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Jun; Vol. 36 (6), pp. e475-e477. Date of Electronic Publication: 2022 Feb 08.

Treatment of basal cell carcinomas and basaloid follicular hamartomas in basal cell nevus syndrome children and adolescents.

Autor: Verkouteren BJA; Department of Dermatology, Maastricht University Medical Center, Maastricht, Netherlands., Mosterd K; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1792-1793. Date of Electronic Publication: 2020 Nov 01.

Molecular testing in metastatic basal cell carcinoma.

Autor: Verkouteren BJA; Department of Dermatology, Maastricht University Medical Center, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: babette.verkouteren@mumc.nl., Wakkee M; Department of Dermatology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., van Geel M; Department of Dermatology, Maastricht University Medical Center, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Winnepenninckx VJ; Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands., Korpershoek E; Department of Pathology, Erasmus University Medical Center Cancer Institute, the Netherlands., Mooyaart AL; Department of Pathology, Erasmus University Medical Center Cancer Institute, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Terra JB; Department of Dermatology, Isala Dermatologic Center, Zwolle, the Netherlands., Aarts MJB; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Reinders MGHC; Department of Dermatology, Maastricht University Medical Center, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Center, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Nov; Vol. 85 (5), pp. 1135-1142. Date of Electronic Publication: 2019 Dec 21.

Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study.

Autor: Verkouteren BJA; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands. babette.verkouteren@mumc.nl.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. babette.verkouteren@mumc.nl., Wakkee M; Department of Dermatology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Nelemans P; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Rácz E; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands., Terra JB; Department of Dermatology, Isala Dermatologic Center, Zwolle, The Netherlands., Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Alers RJ; Department of Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands., Bekkenk MW; Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands., Reinders MGHC; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (7), pp. 1199-1206. Date of Electronic Publication: 2021 Jan 19.